Proteomics

Dataset Information

0

Sublytic membrane attack complex drives glycolysis and mitochondrial dysfunction with inflammatory consequences in human monocyte-derived macrophages


ABSTRACT: The terminal stage of the complement activation pathways, the membrane attack complex (MAC), is upregulated in diabetic and rheumatoid arthritis patients, contributing pathologically by increasing inflammation. Previous research has highlighted that a sublytic dose of MAC can initiate NLRP3 inflammasome activation via calcium influx and loss of mitochondrial membrane potential. Here, we show that sublytic concentrations of MAC mediate a previously undescribed perturbation in cellular energy metabolism in human monocyte-derived macrophages, by phenotypic skewing towards glycolysis and upregulation of glycolysis-promoting genes. Sublytic MAC concentrations drive mitochondrial dysfunction, characterised by a fragmented mitochondrial morphology, loss of maximal respiratory response, depleted mitochondrial membrane potential as well as increased mitochondrial reactive oxygen species production. The consequences of these alterations in glycolytic metabolism and mitochondrial dysfunction lead to NLRP3 inflammasome activation, driving gasdermin D formation and IL-18 release. This novel link between sublytic MAC and immunometabolism, with direct consequences for downstream inflammatory processes, is important for development of novel therapeutics for areas where MAC may mediate disease.

INSTRUMENT(S): Q Exactive

ORGANISM(S): Homo Sapiens (human)

TISSUE(S): Primary Cell, Monocyte, Blood

SUBMITTER: Eleanor Dickinson  

LAB HEAD: Roland Annan

PROVIDER: PXD027316 | Pride | 2023-03-11

REPOSITORIES: Pride

altmetric image

Publications


The complement system is an ancient and critical part of innate immunity. Recent studies have highlighted novel roles of complement beyond lysis of invading pathogens with implications in regulating the innate immune response, as well as contributing to metabolic reprogramming of T-cells, synoviocytes as well as cells in the CNS. These findings hint that complement can be an immunometabolic regulator, but whether this is also the case for the terminal step of the complement pathway, the membrane  ...[more]

Similar Datasets

2021-09-23 | ST001922 | MetabolomicsWorkbench
2022-03-09 | GSE197606 | GEO
2012-12-01 | E-GEOD-35601 | biostudies-arrayexpress
2014-07-01 | E-GEOD-58959 | biostudies-arrayexpress
2022-11-15 | ST002379 | MetabolomicsWorkbench
2022-11-16 | ST002378 | MetabolomicsWorkbench
2022-11-15 | ST002371 | MetabolomicsWorkbench
2011-05-22 | E-GEOD-27960 | biostudies-arrayexpress
2022-11-29 | PXD033497 | Pride
2021-05-17 | PXD024915 | Pride